Codexis Inc. (NASDAQ: CDXS)
$3.72
+0.4500 ( +13.76% ) 778.2K
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
Market Data
Open
$3.72
Previous close
$3.27
Volume
778.2K
Market cap
$261.77M
Day range
$3.21 - $3.75
52 week range
$1.45 - $4.91
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 02, 2024 |
def | Proxies and info statements | 20 | Apr 25, 2024 |
8-k | 8K-related | 15 | Mar 06, 2024 |
8-k | 8K-related | 16 | Feb 28, 2024 |
10-k | Annual reports | 126 | Feb 28, 2024 |
8-k | 8K-related | 14 | Feb 16, 2024 |
8-k | 8K-related | 15 | Feb 13, 2024 |
8-k | 8K-related | 15 | Feb 09, 2024 |
8-k | 8K-related | 12 | Jan 09, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |